Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Alpha Teknova, Inc. (TKNO)

Teknova Q3 revenue rises 22% to $12.7 million and 2026 revenue guidance is raised

Positive Impact 4 of 5 earnings Written later

Alpha Teknova reported third-quarter 2026 revenue of $12.7 million, up 22% from a year earlier, and its net loss narrowed to $3.5 million from $4.3 million. The company raised its 2026 revenue guidance to $46 million to $48 million and closed a $46.0 million public offering of 9.2 million shares at $5.00 per share on October 22, 2026, which adds to the shares held by existing shareholders.

Key points

  • Q3 2026 revenue was $12.7 million, up 22% from $10.5 million; Clinical Solutions revenue rose 86% to $3.2 million.
  • Net loss was $3.5 million, or $0.06 per diluted share, versus $4.3 million, or $0.08 per share, in Q3 2025.
  • 2026 revenue guidance raised to $46 million to $48 million; Free Cash Outflow guidance of less than $8 million was maintained.
  • Underwritten offering of 9.2 million shares at $5.00 closed October 22, 2026, with gross proceeds of $46.0 million and net proceeds of about $42.9 million.

The filing

CompanyAlpha Teknova, Inc. (TKNO)
Form8-K, current report
Filed with the SECNov 4, 2026, 4:11 PM ET
Accession number0001850902-26-000015

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:44 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 04, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.